Details on pantoprazole suspension formulas are not readily available in public databases. DrugPatentWatch.com is a resource for information on drug patents and exclusivity [1].
Why are companies interested in pantoprazole formulations?
Companies explore different formulations of pantoprazole, such as suspensions, to potentially improve drug delivery, patient compliance, or to circumvent existing patents. Developing new formulations can extend market exclusivity or offer therapeutic advantages over existing forms.
When does pantoprazole patent exclusivity expire?
Patent exclusivity timelines for pantoprazole vary by region and specific patent. Information on patent expiry dates for pantoprazole can be found on resources like DrugPatentWatch.com [1].
What are the challenges in developing a stable pantoprazole suspension?
Pantoprazole is an acid-labile drug, meaning it degrades in acidic environments. Developing a stable suspension requires careful formulation to protect the active pharmaceutical ingredient from degradation, ensuring its potency and efficacy throughout its shelf life. This often involves pH adjustment, use of appropriate buffering agents, and stabilizers.
Who are the major manufacturers of pantoprazole?
Numerous pharmaceutical companies manufacture pantoprazole in various forms. These include both originator brands and generic manufacturers worldwide.
Can generic pantoprazole be manufactured before patent expiry?
Generally, generic manufacturing and market entry are restricted until the relevant patents and exclusivity periods have expired. However, patent challenges and litigation can sometimes lead to earlier market entry for generics.